Company in focus
Bilfinger benefited from takeover speculation. BMW and Toyota expand their fuel cell collaborations. The first series model, the X5, is due to hit the market in 2022. BioNTech gained today after speculation that the biotech company could soon get British approval for the corona vaccine. Approval in the USA has already been applied for. Merck plans to purchase biopharmaceutical company Oncoimmune. The group currently has an active ingredient against Covid-19 in development. HelloFresh has an eye on Factor75 to grow its US business. The share was still lower today. Siemens works together with Deutsche Bahn on the development of hydrogen-powered trains. The news was well received by investors. The hope for government support spurred the stocks of the steel companies today Salzgitter and ThyssenKrupp. At SAF Holland the good order numbers still had an effect. Among the internationally diversified industry and strategy indices were the Global Hydrogen Index, the Stoxx® Europe Banks and the Solactive® European Mergers & Acquisitions Index very popular.